CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Treasury Stock	Accumulated Other Comprehensive Income (Loss)	Accumulated Earnings
Balance, beginning of period, shares at Dec. 31, 2022		31,269,000
Balance, beginning of period at Dec. 31, 2022	$ 355,249	$ 708	$ 495,189	$ (1,018,034)	$ (58,829)	$ 936,215
Net Income (Loss)	66,246					66,246
Foreign currency translation adjustments	8,416				8,416
Total comprehensive income	74,662
Repurchase of common stock, shares		(2,369,000)
Repurchase of common stock	(128,179)	$ (2)	(10,156)	(118,021)
Issuance of common stock pursuant to employee stock purchase plan	3,284		3,284
Issuance of common stock pursuant to employee stock purchase plan, shares		74,000
Issuance of restricted common stock pursuant to stock-based compensation plans, shares		666,000
Issuance of restricted common stock pursuant to stock-based compensation plans		$ 7	(7)
Cancellation of restricted common stock issued pursuant to stock-based compensation plans, shares		(99,000)
Stock-based compensation	28,990		28,990
Purchase of capped call transactions, net of tax	(26,353)		(26,353)
Dividends	(34,327)					(34,327)
Balance, ending of period, shares at Dec. 31, 2023		29,541,000
Balance, ending of period at Dec. 31, 2023	273,326	$ 713	490,947	(1,136,055)	(50,413)	968,134
Net Income (Loss)	86,852					86,852
Foreign currency translation adjustments	(11,877)				(11,877)
Total comprehensive income	74,975
Repurchase of common stock, shares		(1,362,000)
Repurchase of common stock	(67,531)	$ (1)	(9,361)	(58,169)
Issuance of common stock pursuant to employee stock purchase plan	3,072		3,072
Issuance of common stock pursuant to employee stock purchase plan, shares		73,000
Issuance of restricted common stock pursuant to stock-based compensation plans, shares		777,000
Issuance of restricted common stock pursuant to stock-based compensation plans	(1)	$ 8	(9)
Cancellation of restricted common stock issued pursuant to stock-based compensation plans		$ (2)	2
Cancellation of restricted common stock issued pursuant to stock-based compensation plans, shares		(175,000)
Stock-based compensation	33,564		33,564
Dividends	$ (34,836)					(34,836)
Balance, ending of period, shares at Dec. 31, 2024	28,854,000	28,854,000
Balance, ending of period at Dec. 31, 2024	$ 282,569	$ 718	518,215	(1,194,224)	(62,290)	1,020,150
Net Income (Loss)	55,881					55,881
Foreign currency translation adjustments	17,248				17,248
Total comprehensive income	73,129
Repurchase of common stock, shares		(1,258,000)
Repurchase of common stock	(82,812)	$ (4)	(33,060)	(49,748)
Issuance of common stock pursuant to employee stock purchase plan	2,473		2,473
Issuance of common stock pursuant to employee stock purchase plan, shares		46,000
Issuance of restricted common stock pursuant to stock-based compensation plans, shares		785,000
Issuance of restricted common stock pursuant to stock-based compensation plans		$ 8	(8)
Cancellation of restricted common stock issued pursuant to stock-based compensation plans		$ (1)	1
Cancellation of restricted common stock issued pursuant to stock-based compensation plans, shares		(57,000)
Stock-based compensation	45,264		45,264
Dividends	$ (36,924)					(36,924)
Balance, ending of period, shares at Dec. 31, 2025	28,370,000	28,370,000
Balance, ending of period at Dec. 31, 2025	$ 283,699	$ 721	$ 532,885	$ (1,243,972)	$ (45,042)	$ 1,039,107